273 related articles for article (PubMed ID: 17143889)
1. Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.
Dimitri D; Andre C; Roucoules J; Hosseini H; Humbel RL; Authier FJ
Muscle Nerve; 2007 Mar; 35(3):389-95. PubMed ID: 17143889
[TBL] [Abstract][Full Text] [Related]
2. Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation.
Rodolico C; Mazzeo A; Toscano A; Pastura C; Maimone D; Musumeci O; Musolino C; Vita G
Neuromuscul Disord; 2006 Aug; 16(8):514-7. PubMed ID: 16919949
[TBL] [Abstract][Full Text] [Related]
3. Patient education pages. Polymyositis.
Kernich CA
Neurologist; 2008 May; 14(3):205-6. PubMed ID: 18469679
[No Abstract] [Full Text] [Related]
4. Anti-signal recognition particle myopathy in the first decade of life.
Suzuki S; Ohta M; Shimizu Y; Hayashi YK; Nishino I
Pediatr Neurol; 2011 Aug; 45(2):114-6. PubMed ID: 21763952
[TBL] [Abstract][Full Text] [Related]
5. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex.
De Bleecker J; Vervaet V; Van den Bergh P
Clin Neuropathol; 2004; 23(2):76-9. PubMed ID: 15074581
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
Suzuki S; Satoh T; Sato S; Otomo M; Hirayama Y; Sato H; Kawai M; Ishihara T; Suzuki N; Kuwana M
Rheumatology (Oxford); 2008 Oct; 47(10):1539-42. PubMed ID: 18687709
[TBL] [Abstract][Full Text] [Related]
7. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
Arlet JB; Dimitri D; Pagnoux C; Boyer O; Maisonobe T; Authier FJ; Bloch-Queyrat C; Goulvestre C; Heshmati F; Atassi M; Guillevin L; Herson S; Benveniste O; Mouthon L
Neuromuscul Disord; 2006 May; 16(5):334-6. PubMed ID: 16616848
[TBL] [Abstract][Full Text] [Related]
8. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
9. A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
Kawabata T; Komaki H; Saito T; Saito Y; Nakagawa E; Sugai K; Sasaki M; Hayashi YK; Nishino I; Momomura M; Kizawa T; Imagawa T; Yokota S
Brain Dev; 2012 Nov; 34(10):877-80. PubMed ID: 22436377
[TBL] [Abstract][Full Text] [Related]
10. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
11. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
12. Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
Liewluck T
Rheumatology (Oxford); 2009 Jan; 48(1):90; author reply 90-1. PubMed ID: 18984607
[No Abstract] [Full Text] [Related]
13. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
Spuler S; Engel AG
Neurology; 1998 Jan; 50(1):41-6. PubMed ID: 9443455
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiology extends the phenotypic spectrum of X-linked myopathy with excessive autophagy.
Munteanu I; Ackerley CA; Mnatzakanian GN; Kissel JT; Minassian BA
Neurology; 2005 Mar; 64(5):927-8. PubMed ID: 15753448
[No Abstract] [Full Text] [Related]
15. Chronic Myopathy Associated With Anti-Signal Recognition Particle Antibodies Can Be Misdiagnosed As Facioscapulohumeral Muscular Dystrophy.
Ikeda K; Mori-Yoshimura M; Yamamoto T; Sonoo M; Suzuki S; Kondo Y; Nakamura H; Mitsuhashi K; Maeda MH; Shimizu J; Hayashi YK; Nishino I; Oya Y; Murata M
J Clin Neuromuscul Dis; 2016 Jun; 17(4):197-206. PubMed ID: 27224434
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
Cherin P
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
[TBL] [Abstract][Full Text] [Related]
18. X-linked vacuolated myopathy: complement membrane attack complex on surface membrane of injured muscle fibers.
Villanova M; Louboutin JP; Chateau D; Eymard B; Sagniez M; Tomé FM; Fardeau M
Ann Neurol; 1995 May; 37(5):637-45. PubMed ID: 7755359
[TBL] [Abstract][Full Text] [Related]
19. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Miller T; Al-Lozi MT; Lopate G; Pestronk A
J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):420-8. PubMed ID: 12235311
[TBL] [Abstract][Full Text] [Related]
20. Polyglucosan body disease myopathy: an unusual presentation.
Vucic S; Pamphlett R; Wills EJ; Yiannikas C
Muscle Nerve; 2007 Apr; 35(4):536-9. PubMed ID: 17221878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
